Life Clips intends to utilize Cognitive Apps speech-based AI technology to help accurately predict risk for various types of depression and mood, psychotic and anxiety-based disorders
Partnership intends to obtain licences and permits to legally possess, supply, sell and manufacture Schedule 8 & 9 drugs (Schedule 9 is equivalent to America’s Schedule 1) in order to produce cGMP psychedelics...
Acquisition will allow the Company to utilize speech-based AI technology to help accurately predict risk for various types of depression and mood and anxiety-based disorders
Pharmaceutically pure biosynthetic compounds are expected to be promising contenders to replace synthetic and plant-extracted psychedelics.
MIAMI, Feb. 08, 2021 (GLOBE NEWSWIRE) -- 20/20 Global, Inc., (OTC Pink: TWGL) “Mycotopia”, a company focused on psychedelic therapies, announced today that it has applied to the Financial Industry...
An online Ketamine roundtable event for Psychedelic experts, investors and enthusiasts
Company intends to focus on opportunities in the psychedelic space in the Caribbean and distribute Global 20/20 shares at a later date.
The Top Companies Addressing Mental Health Crisis
MIAMI, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics and developer of KetaDASH, a home delivery platform for patients who have...